|
structural constituent of proteasome
|
GO_0140756 |
[The action of a molecule that contributes to the structural integrity of the proteasome.] |
|
ADP-riboxanase activity
|
GO_0140740 |
[Catalysis of the reaction: L-arginyl-[protein] + NAD+ = ADP-riboxanated L-argininyl-[protein] + H+ + NH4(+) + nicotinamide.] |
|
phlorizin hydrolase activity
|
GO_0140749 |
[Catalysis of the reaction: phlorizin + H2O = beta-D-glucose + phloretin.] |
|
negative regulation of lncRNA transcription
|
GO_0140744 |
[Any process that decreases the frequency, rate or extent of the synthesis of a lncRNA.] |
|
regulation of lncRNA transcription
|
GO_0140743 |
[Any process that modulates the frequency, rate or extent of the synthesis of a lncRNA.] |
|
lncRNA transcription
|
GO_0140742 |
[The transcription of lncRNAs, non-coding RNAs over 200 nucleotides in length, from a DNA template.] |
|
tRNA-uracil-4 sulfurtransferase activity
|
GO_0140741 |
[Catalyzes the reaction: ATP + [ThiI sulfur-carrier protein]-S-sulfanyl-L-cysteine + uracil in tRNA + 2 reduced ferredoxin [iron-sulfur] cluster = AMP + diphosphate + 4-thiouracil in tRNA + [ThiI sulfur-carrier protein]-L-cysteine + 2 oxidized ferredoxin [iron-sulfur] cluster.] |
|
positive regulation of regulation of ascospore wall (1->3)-beta-D-glucan biosynthetic process
|
GO_0140748 |
[Any process that activates or increases the frequency, rate or extent of ascospore wall (1->3)-beta-D-glucan biosynthetic process.] |
|
obsolete regulation of ncRNA transcription
|
GO_0140747 |
[OBSOLETE. Any process that modulates the frequency, rate or extent of transcription of a non-protein coding gene from a DNA-template.] |
|
siRNA catabolic process
|
GO_0140746 |
[The chemical reactions and pathways resulting in the breakdown of small interfering RNA transcripts (siRNAs).] |
|
siRNA transcription
|
GO_0140745 |
[The transcription of a small interfering RNA from an RNA template.] |
|
NLRP6 inflammasome complex assembly
|
GO_0140739 |
[The aggregation, arrangement and bonding together of a set of components to form a NLRP6 inflammasome complex.] |
|
NLRP6 inflammasome complex
|
GO_0140738 |
[An inflammasome complex that consists of NLRP6, PYCARD/ASC and caspase-1 or caspase-4/caspase-11.] |
|
tRNA ligase activator activity
|
GO_0140733 |
[Binds to and increases the activity of a tRNA ligase.] |
|
positive regulation of amphiregulin production
|
GO_0140732 |
[Any process that activates or increases the frequency, rate or extent of production of amphiregulin.] |
|
regulation of amphiregulin production
|
GO_0140731 |
[Any process that modulates the frequency, rate, or extent of production of amphiregulin.] |
|
amphiregulin production
|
GO_0140730 |
[The appearance of amphiregulin due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Amphiregulin (AREG) is a ligand of the epidermal growth factor receptor (EGFR), a widely expressed transmembrane tyrosine kinase. AREG is synthesized as a membrane-anchored precursor protein that can engage in juxtacrine signaling on adjacent cells. Alternatively, after proteolytic processing by cell membrane proteases, mainly TACE/ADAM17, AREG is secreted and behaves as an autocrine or paracrine factor.] |
|
encapsulin nanocompartment
|
GO_0140737 |
[Intracellular non-membrane bound organelle, consisting of proteinaceous polyhedral shells that encapsulate enzymes, protecting the contents from their surrounding milieu and/or the milieu from reactants in their interior. The self-assembling, 25-42 nm nanocompartment shell, unlike larger bacterial microcompartments, is made of only one protein, and has only a few proteins inside. Shells about vary from about 25-42 nm in diameter. The shell protein has an HK97-like fold and probably evolved from a viral protein. Artificial encapsulin nanocompartments can be expressed and filled with cargo proteins for biotechnological uses. They are found in many bacterial and a few archaeal phyla.] |
|
positive regulation of lovastatin biosynthetic process
|
GO_0140736 |
[Any process that increases the rate, frequency or extent of the chemical reactions and pathways resulting in the formation of lovastin.] |
|
lovastatin biosynthetic process
|
GO_0140735 |
[The chemical reactions and pathways resulting in the formation of lovastatin (also known as mevinolin, mevacor or monacolin K), a hypolipidemic inhibitor of (3S)-hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase (HMGR).] |